State Street Corp Theravance Biopharma, Inc. Transaction History

State Street Corp

$2.59 Trillion
Q2 2025

A detailed history of State Street Corp transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, State Street Corp holds 1,035,648 shares of TBPH stock, worth $12.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,035,648

Previous 1,066,775 2.92%

Holding current value

$12.3 Million

Previous $9.53 Million 19.91%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$8.32 - $11.25 $258,976 - $350,178	-31,127 Reduced 2.92%	1,035,648 $11.4 Million
Q1 2025 May 15, 2025	SELL	$8.44 - $10.47 $1.31 Million - $1.63 Million	-155,695 Reduced 12.74%	1,066,775 $9.53 Million
Q4 2024 Feb 14, 2025	BUY	$7.93 - $10.08 $244,632 - $310,957	30,849 Added 2.59%	1,222,470 $11.5 Million
Q3 2024 Nov 14, 2024	SELL	$7.66 - $10.25 $580,275 - $776,478	-75,754 Reduced 5.98%	1,191,621 $9.6 Million
Q2 2024 Aug 14, 2024	SELL	$8.29 - $9.92 $840,655 - $1.01 Million	-101,406 Reduced 7.41%	1,267,375 $10.7 Million
Q1 2024 May 15, 2024	SELL	$8.22 - $11.59 $177,001 - $249,567	-21,533 Reduced 1.55%	1,368,781 $12.3 Million
Q4 2023 Feb 14, 2024	SELL	$8.58 - $11.4 $693,890 - $921,952	-80,873 Reduced 5.5%	1,390,314 $15.6 Million
Q3 2023 Nov 14, 2023	SELL	$8.38 - $10.44 $51,126 - $63,694	-6,101 Reduced 0.41%	1,471,187 $12.7 Million
Q2 2023 Aug 14, 2023	BUY	$10.16 - $11.92 $673,404 - $790,057	66,280 Added 4.7%	1,477,288 $15.3 Million
Q1 2023 May 15, 2023	SELL	$9.87 - $11.44 $216,261 - $250,661	-21,911 Reduced 1.53%	1,411,008 $15.3 Million
Q4 2022 Feb 14, 2023	SELL	$9.65 - $11.34 $500,256 - $587,865	-51,840 Reduced 3.49%	1,432,919 $16.1 Million
Q3 2022 Nov 15, 2022	SELL	$8.39 - $10.22 $86,307 - $105,133	-10,287 Reduced 0.69%	1,484,759 $15.1 Million
Q2 2022 Aug 15, 2022	SELL	$8.41 - $10.34 $390,955 - $480,675	-46,487 Reduced 3.02%	1,495,046 $13.5 Million
Q1 2022 May 16, 2022	BUY	$8.33 - $12.96 $1.51 Million - $2.35 Million	181,331 Added 13.33%	1,541,533 $14.7 Million
Q4 2021 Feb 14, 2022	SELL	$7.42 - $11.05 $89,373 - $133,097	-12,045 Reduced 0.88%	1,360,202 $15 Million
Q3 2021 Nov 15, 2021	BUY	$6.77 - $14.41 $786,599 - $1.67 Million	116,189 Added 9.25%	1,372,247 $10.2 Million
Q2 2021 Aug 16, 2021	BUY	$14.52 - $22.46 $1.5 Million - $2.32 Million	103,439 Added 8.97%	1,256,058 $18.2 Million
Q1 2021 Jul 09, 2021	BUY	$16.57 - $21.08 $2.64 Million - $3.36 Million	159,616 Added 16.07%	1,152,619 $23.5 Million
Q1 2021 May 17, 2021	SELL	$16.57 - $21.08 $933,586 - $1.19 Million	-56,342 Reduced 5.37%	993,003 $20.3 Million
Q4 2020 Feb 16, 2021	SELL	$14.89 - $20.16 $630,427 - $853,554	-42,339 Reduced 3.88%	1,049,345 $18.6 Million
Q3 2020 Nov 10, 2020	SELL	$14.79 - $22.49 $209,234 - $318,166	-14,147 Reduced 1.28%	1,091,684 $16.1 Million
Q2 2020 Aug 14, 2020	BUY	$20.64 - $30.69 $1.04 Million - $1.55 Million	50,563 Added 4.79%	1,105,831 $23.2 Million
Q1 2020 May 11, 2020	BUY	$17.84 - $31.21 $18.8 Million - $32.9 Million	1,055,268 New	1,055,268 $24.4 Million

Others Institutions Holding TBPH

# of Institutions

138

Shares Held

48.1M

Call Options Held

Put Options Held

11.6K

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $796M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Theravance Biopharma, Inc. Transaction History